Clinical, immunological features, treatments, and outcomes of autoimmune hemolytic anemia in patients with RAG deficiency.

Authors:
Wang C; Sun B; Wu K; Farmer JR; Ujhazi B and 29 more

Journal:
Blood Adv

Publication Year: 2024

DOI:
10.1182/bloodadvances.2023011264

PMCID:
PMC10837476

PMID:
37883797

Journal Information

Full Title: Blood Adv

Abbreviation: Blood Adv

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict-of-interest: J.R.F. is an ongoing consultant for Pharming and has received investigator-initiated research grants from Pfizer, Bristol Myers Squibb, and Pharming, with no direct relation to the work presented. K. Chen is a consultant at Immune Deficiency Foundation and Horizon Therapeutics, and is a part of the speaker’s bureau for Takeda. J.E.W. reports grant/research/clinical trial support provided by Takeda (Immunology), Janssen (Hematology), Chiesi (Immunology), MustangBio (Immunology), ADMA Biologicals (Immunology), Octapharma (Immunology), X4-Pharmaceuticals (Immunology), Novartis (Allergy), Regeneron (Allergy), and Bristol Myers Squibb (Immunology); consultant/advisory board fees from Takeda (Immunology), X4-Pharmaceuticals (Immunology), CSL-Behring (Immunology), Grifols (Immunology), ADMA Biologicals (Immunology), Enzyvant (Immunology), Regeneron (Immunology), and Pharming (Immunology); speaker’s bureau fees from Takeda (Immunology) and Pharming (Immunology); and is a medical writer for UpToDate. The remaining authors declare no competing financial interests."

Evidence found in paper:

"C.W. is supported in part by the Division of Clinical Research, 10.13039/100000060National Institute of Allergy and Infectious Diseases, 10.13039/100000002National Institutes of Health. J.R.F. was supported by a faculty development award from the 10.13039/100002567American Academy of Allergy Asthma & Immunology and the 10.13039/100006545National Institute on Minority Health and Health Disparities of the 10.13039/100000002National Institutes of Health under award number R01MD017816. L.D.N. is supported by the 10.13039/100006492Division of Intramural Research, National Institute of Allergy and Infectious Diseases, 10.13039/100000002National Institutes of Health (grant ZIA AI001222). J.E.W. is supported by the 10.13039/100000060National Institute of Allergy and Infectious Diseases, 10.13039/100000002National Institutes of Health 5K08AI103035, sub-R01AI100887-05 and R01AI153830-05, Robert A. Good Endowment at 10.13039/100008900University of South Florida, and 10.13039/100001245Jeffrey Modell Foundation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025